Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

ClinicalTrials.gov ID: NCT00245622

Public ClinicalTrials.gov record NCT00245622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Tovaxin in Subjects With CIS or RR-MS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 1 year study to evaluate the efficacy, safety, and tolerability of Tovaxin T cell therapy in subjects with a clinically isolated syndrome (CIS) and relapse-remitting multiple sclerosis (RR-MS).

Study identification

NCT ID
NCT00245622
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Opexa Therapeutics, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Mar 10, 2014

2006 – 2008

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
North Central Neurology Associates, PC Cullman Alabama 35058 —
Xenoscience - 21st Century Neurology Phoenix Arizona 85013 —
HOPE Research Institute Phoenix Arizona 85050 —
Alta Bates Summit Medical Center - East Bay Physicians Medical Group Berkeley California 94705 —
Patricia A Fodor, PC Colorado Springs Colorado 80919 —
Bradenton Neurology Bradenton Florida 34205 —
Neurological Associates Pompano Beach Florida 33060 —
Lovelace Scientific Resources Sarasota Florida 34233 —
Shepherd Center Atlanta Georgia 30309 —
Medical College of Georgia - Department of Neurology Augusta Georgia 30912 —
Consultants in Neurology, Ltd. Northbrook Illinois 60062 —
Allied Physicians Inc Fort Wayne Indiana 46805 —
MidAmerica Neuroscience Institute Lenexa Kansas 66214 —
Associates in Neurology Lexington Kentucky 40503 —
University of Louisville Hospital Louisville Kentucky 40202 —
Research Nurse Specialists Lafayette Louisiana 70503 —
St Mary's of Michigan - Field Neuroscience Institute Saginaw Michigan 48604 —
Ayres & Associates Clinical Trials Lebanon New Hampshire 03766 —
Upstate Clinical Research, LLC Albany New York 12205 —
Winthrop University Hospital - Clinical Trials Unit Mineola New York 11501 —
University Hospital and Medical Center Stony Brook New York Stony Brook New York 11794-8121 —
Neurology Consultants of the Carolinas, PA Charlotte North Carolina 28204 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Neurology & Neuroscience Associates, Inc. Akron Ohio 44302 —
Neurological Research Institute Columbus Ohio 43221 —
Neurology Specialists, Inc Dayton Ohio 45408 —
Providence St. Vincent Medical Center - Northwest MS Center Portland Oregon 97225 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
The Maxine Mesinger MS Clinic/Baylor College of Medicine Houston Texas 77030 —
Central Texas Neurology Round Rock Texas 78681 —
Integra Clinical Research, LLC San Antonio Texas 78229 —
MS Center at Evergreen Kirkland Washington 98101 —
Capitol Neurology Charleston West Virginia 25301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00245622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00245622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →